Zacks Investment Research Downgrades Fortress Biotech Inc. (FBIO) to Sell

Zacks Investment Research Downgrades Fortress Biotech Inc. (FBIO) to Sell


According to Zacks, "Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products.



from Biotech News